Sign in
Safety and Efficacy of Brepocitinib, a TYK2/JAK1 Inhibitor, in Active Non-Infectious Uveitis: 24-Week Results from a 52-Week Phase 2 Study (NEPTUNE)
Robert C. Wang, MD, FASRS
Annual Meeting Talks
2024
Central Retinal Artery Occlusion as the Inaugural Sign of Takayasu Disease
Naresh Babu Kannan, MS, FNB(V R),MBA (H R),FASRS,.
On Demand Cases, Courses, and Papers
2019
Retinal Vascular Disease: CRAO or Is It?
Shree K. Kurup, MD
Category: Inflammatory and Infectious Diseases- Helminthic Infections